Vanguard Group’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.6M | Buy |
2,108,938
+26,332
| +1% | +$1.14M | ﹤0.01% | 1864 |
|
|
2025
Q1 | $77.8M | Sell |
2,082,606
-14,991
| -0.7% | -$560K | ﹤0.01% | 1899 |
|
|
2024
Q4 | $95M | Sell |
2,097,597
-29,445
| -1% | -$1.33M | ﹤0.01% | 1897 |
|
|
2024
Q3 | $125M | Buy |
2,127,042
+156,722
| +8% | +$9.21M | ﹤0.01% | 1769 |
|
|
2024
Q2 | $77.5M | Buy |
1,970,320
+101,654
| +5% | +$4M | ﹤0.01% | 1956 |
|
|
2024
Q1 | $124M | Buy |
1,868,666
+705,795
| +61% | +$46.9M | ﹤0.01% | 1756 |
|
|
2023
Q4 | $32.5M | Buy |
1,162,871
+41,107
| +4% | +$1.15M | ﹤0.01% | 2370 |
|
|
2023
Q3 | $23.9M | Buy |
+1,121,764
| New | +$23.9M | ﹤0.01% | 2481 |
|